APA (7th ed.) Citation

Bitler, B. G., Watson, Z. L., Wheeler, L. J., & Behbakht, K. (2017). PARP inhibitors: Clinical utility and possibilities of overcoming resistance. Gynecologic Oncology, 147(3), 695. https://doi.org/10.1016/j.ygyno.2017.10.003

Chicago Style (17th ed.) Citation

Bitler, Benjamin G., Zachary L. Watson, Lindsay J. Wheeler, and Kian Behbakht. "PARP Inhibitors: Clinical Utility and Possibilities of Overcoming Resistance." Gynecologic Oncology 147, no. 3 (2017): 695. https://doi.org/10.1016/j.ygyno.2017.10.003.

MLA (9th ed.) Citation

Bitler, Benjamin G., et al. "PARP Inhibitors: Clinical Utility and Possibilities of Overcoming Resistance." Gynecologic Oncology, vol. 147, no. 3, 2017, p. 695, https://doi.org/10.1016/j.ygyno.2017.10.003.